159 related articles for article (PubMed ID: 37323605)
1. Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma.
Singh P; Tahlan A; Mohan H; Singh R
J Lab Physicians; 2023 Jun; 15(2):282-288. PubMed ID: 37323605
[No Abstract] [Full Text] [Related]
2. Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.
Hazar B; Paydas S; Zorludemir S; Sahin B; Tuncer I
Leuk Lymphoma; 2003 Dec; 44(12):2089-93. PubMed ID: 14959852
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density.
Aggarwal D; Srivastava G; Gupta R; Pant L; Krishan G; Singh S
ISRN Hematol; 2012; 2012():943089. PubMed ID: 22536524
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
[TBL] [Abstract][Full Text] [Related]
5. Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.
; Kataria SP; Malik S; Yadav R; Kapil R; Sen R
J Lab Physicians; 2021 Mar; 13(1):22-28. PubMed ID: 34149231
[No Abstract] [Full Text] [Related]
6. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pediatr Hematol Oncol; 2008; 25(1):55-66. PubMed ID: 18231955
[TBL] [Abstract][Full Text] [Related]
7. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma.
Chhieng DC; Tabbara SO; Marley EF; Talley LI; Frost AR
Breast J; 2003; 9(3):200-7. PubMed ID: 12752628
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in non-Hodgkin's lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Olsen ML; Funder AM; d'Amore F
Leuk Lymphoma; 2007 Mar; 48(3):584-95. PubMed ID: 17454603
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.
Koh YW; Han JH; Yoon DH; Suh C; Huh J
Hematol Oncol; 2018 Feb; 36(1):182-188. PubMed ID: 28744882
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Angiogenesis in Multiple Myeloma by VEGF Immunoexpression and Microvessel Density.
Palta A; Kaur M; Tahlan A; Dimri K
J Lab Physicians; 2020 Mar; 12(1):38-43. PubMed ID: 32792792
[No Abstract] [Full Text] [Related]
12. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression in low and high grade B-cell non-Hodgkin's lymphomas.
Ozbudak IH; Akkaya B; Karpuzoğlu G
Turk Patoloji Derg; 2011; 27(3):204-9. PubMed ID: 21935869
[TBL] [Abstract][Full Text] [Related]
14. Morphometric angiogenesis parameters for indolent and aggressive non-Hodgkin's lymphoma.
Kopic E; Cickusic E; Kopic A; Arnautovic-Custovic A; Halilbasic A; Tinjic L; Hasic S; Simendic V
Med Arh; 2011; 65(1):9-12. PubMed ID: 21534443
[TBL] [Abstract][Full Text] [Related]
15. Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies.
Chand R; Chandra H; Chandra S; Verma SK
Bone Marrow Res; 2016; 2016():5043483. PubMed ID: 26998362
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma.
Shahini L; Gašparov S; Petruševska G; Manxhuka Kerliu S; Veselaj F; Kurshumliu F; Kavaja F
Acta Clin Croat; 2017 Dec; 56(4):588-593. PubMed ID: 29590710
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
18. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
19. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]